7 best EDC platforms for SMID CROs in 2026

When a protocol amendment takes 90 days to implement in your electronic data capture (EDC) platform, you're not just waiting for a build update -- you're watching billing timelines slip, sponsor confidence erode, and operational margin compress across every study in your portfolio. Viedoc's EDC software delivers study builds typically completed in 2--4 weeks, with a no-code Designer your certified data managers can operate independently, backed by 24/7 customer success and a track record spanning 7,000+ completed studies across 75+ countries. This comparison evaluates seven leading EDC platforms for small and mid-sized (SMID) contract research organizations (CROs) across study build speed, no-code configuration, compliance credentials, and total cost of ownership.

Running 10, 20, or 50 concurrent studies means that amendment lag compounds. A single change request that takes two months to implement isn't an inconvenience -- it's a delivery risk replicated across your entire study portfolio, and it's a cost you absorb without recovering it from the sponsor. The platforms you standardize on shape your margins as reliably as your headcount does.

Enterprise EDC platforms built for large pharma's Phase III programs bring real compliance depth, but at a deployment cost and configuration complexity that doesn't translate to a SMID CRO running Phase I and Phase II studies at pace. What this segment needs is right-sized: fast to deploy, compliant by design, transparent on cost, and supported without a ticket queue.

Best EDC solutions for SMID CROs: quick comparison

These seven EDC platforms represent the options SMID CROs most commonly shortlist, reviewed across study build speed, no-code configuration capability, compliance credentials, and total cost of ownership.

1. Viedoc

Viedoc's EDC software is designed for exactly the operational profile of SMID CROs: high study volume, lean team configuration, Phase I and Phase II regulatory rigor, and a pricing model that doesn't penalize portfolio growth. Study builds are typically completed in 2--4 weeks, a direct delivery advantage versus the 90-day standard associated with enterprise platforms like Medidata.

Viedoc Designer is a no-code study configuration environment that allows your certified data management team to build and amend studies in-house, without reliance on vendor-side programmers. For SMID CROs running concurrent studies, this matters: every protocol amendment your team implements independently is a billable activity your organization controls, rather than a change request routed through an external queue. The Viedoc Inspection Readiness Packet (VIRP) provides structured audit-readiness documentation available to all customers, supporting QA teams through FDA and EMA inspections without additional professional services overhead.

Viedoc is ISO 27001 and SOC 2 certified, hosted on Microsoft Azure, and compliant with 21 CFR Part 11, EU Annex 11, GDPR, HIPAA, and ICH-GCP. The platform is available in 40+ languages and used across 30,000+ sites globally, with 24/7 customer success available across Viedoc's offices in North America, Europe, and Asia-Pacific. Pricing is study-based with unlimited user seats and no per-user fees -- which means a growing CRO headcount doesn't translate into a growing platform bill.

"Viedoc takes less time to train designers because of its uncomplicated functions and structure." -- Pragathi G., Enterprise, verified G2 review

Verified proof points:

• Study scale: 7,000+ studies run on Viedoc across 75+ countries
• User base: 140,000+ users globally; 30,000+ sites
• Build speed: Study builds typically completed in 2--4 weeks
• Uptime: 99.99% platform uptime; hosted on Microsoft Azure
• Pricing: Unlimited user seats; no per-user fees; transparent, study-based licensing
• Compliance: 21 CFR Part 11, GDPR, EU Annex 11, HIPAA; ISO 27001 and SOC 2 certified
• Inspection readiness: Viedoc Inspection Readiness Packet (VIRP) available to all customers
• Support: 24/7 support across global offices
• No-code designer: Studies configured in-house by certified data managers; no vendor-side programmer required
• CRO channel: Tiered CRO Partner Program with certified CRO network

2. Medidata

Medidata offers Rave EDC, the dominant enterprise electronic data capture platform globally, used in over 36,000 trials. Owned by Dassault Systèmes since 2019, Medidata is the procurement default for large pharmaceutical companies and global CROs running complex Phase III programs. Rave EDC supports advanced scripting for complex edit checks, deep integration with Medidata's CTMS, safety, and eCOA modules, and full table-stakes feature delivery including source data verification (SDV), log-lines, batch signing, and audit trails. Study builds and protocol amendments typically operate on longer timelines and require trained programmers for configuration, which increases the total cost of deployment for SMID CROs relative to no-code alternatives. In early 2025, Medidata introduced Rave Lite as a lighter-weight offering targeting budget-constrained early-phase studies, though it operates as a constrained version of the full Rave platform rather than an independently architected product.

3. Veeva Vault EDC

Veeva offers Vault EDC as part of the Vault Clinical suite, a modern cloud platform that integrates EDC with Vault eTMF, CTMS, regulatory information management, and safety modules under a single environment. Vault EDC uses a low-code configuration model and delivers zero-downtime updates, which is operationally valuable for sponsors running concurrent trials. The primary value proposition of Vault EDC is its integration within the broader Vault ecosystem: for sponsors already using Vault for other modules, adding EDC eliminates cross-platform data reconciliation. CRO adoption of Vault EDC is lower than sponsor adoption, and the platform's pricing reflects an enterprise positioning that can be difficult to justify for SMID CROs that do not use the full Vault stack. Configuration complexity and onboarding timelines are meaningful for organizations without an existing Vault footprint.

4. Castor EDC

Castor EDC is a cloud-native, no-code EDC platform headquartered in the Netherlands, with ePRO and eConsent modules included in its suite. Castor supports a REST API and promotes integrations with EMR/EHR systems and eConsent solutions, along with trial tokenization capabilities for real-world data linkage powered by Datavant. The platform has a strong presence in European academic and digital health studies, and is increasingly evaluated for early-phase commercial trials. Castor's compliance credentials include 21 CFR Part 11 and GDPR coverage, and the platform is well-regarded for ease of use at the study designer level. Castor does not offer native medical coding or a formal CRO partner program, which limits its fit for SMID CROs managing complex multi-site studies or requiring integrated coding workflows.

5. Medrio

Medrio offers a cloud-based EDC platform with offline data capture capability and modules for ePRO, eConsent, and randomization and trial supply management (RTSM). Medrio has a documented presence in Phase I clinical pharmacology settings and medical device trials, and the platform supports studies across 100+ countries. Offline data capture is a functional differentiator for sites with limited or intermittent connectivity. Medrio's study configuration is designed to be accessible to non-technical users, and the platform is generally positioned at the SMID end of the market. The platform's analytics and reporting capabilities are considered mid-tier relative to the broader eClinical suite depth available from larger vendors, and its adoption in the CRO preferred-vendor market is more limited than Viedoc's or Medidata's.

6. Oracle InForm

Oracle Health offers InForm as its primary EDC product, with deep integration to Oracle's broader health sciences suite including safety, CTMS, and data warehousing tools. Oracle InForm has historically served large pharmaceutical companies and global CROs managing complex, multi-site Phase III trials, and carries deep integration libraries built up over decades of enterprise deployment. The platform's user interface is widely regarded in the market as legacy, and Oracle's mid-market focus has declined as the company has concentrated on large enterprise accounts. Configuration requires programmer involvement, and the total cost of ownership for SMID CROs is significantly higher than for no-code alternatives. Oracle InForm appears infrequently in SMID CRO evaluation shortlists in 2026.

What to look for in EDC solutions for SMID CROs

Amendment velocity and change control overhead

The ability to implement protocol amendments quickly -- without routing a change request through the vendor's programmer team -- is one of the most consequential capability differences between EDC platforms for CROs. What matters is not just initial study build time but amendment turnaround: how long it takes from a protocol change notification to an updated, validated electronic case report form (eCRF) live in the system. For SMID CROs running multiple concurrent studies, amendment lag accumulates across the portfolio. Best practice is a no-code Designer environment where your certified data managers action changes in-house, with a structured version control and audit trail that satisfies regulatory review. A 2--4 week amendment cycle versus a 90-day vendor-managed process is a direct operational margin difference.

In-house configuration versus vendor dependency

Whether your team can configure and amend studies independently -- or whether you depend on vendor-side programmers for every change -- determines your operational agility and your cost base. No-code platforms enable in-house certified data managers to build studies without technical backgrounds. Vendor-dependent platforms require external resource scheduling for each configuration request, which introduces timeline risk outside your control. Best-in-class for SMID CROs is a fully no-code Designer with a structured certified designer training pathway that lets your team develop in-house EDC capability and reduces external service costs over time.

Compliance coverage and inspection readiness tooling

CROs carry compliance responsibility on behalf of sponsors, and the compliance posture of your EDC platform is scrutinized at both the request for proposal (RFP) stage and during FDA or EMA inspections. The baseline requirements -- 21 CFR Part 11, ICH-GCP, EU Annex 11, GDPR, and HIPAA -- should be confirmed as production-delivered, not aspirational. Beyond certifications, what distinguishes platforms is the quality of inspection readiness documentation. Structured audit readiness packets -- like Viedoc's VIRP -- translate your compliance posture into documented evidence your QA team can present at inspection without bespoke preparation. The absence of this tooling shifts the compliance preparation burden onto your internal team.

Pricing model transparency and total cost of ownership

The list price of an EDC platform is rarely the total cost. Per-user fees compound as your CRO headcount grows. Programmer fees accumulate with every protocol amendment. Professional services costs scale with study complexity. For SMID CROs managing narrow margins per study, the pricing model structure matters as much as the headline rate. The most favorable models for CROs are study-based licensing with unlimited user seats -- where headcount growth and organizational scale don't translate into a proportionally higher platform bill. Scrutinize contract terms for per-seat fees, amendment charges, and support tiers that gate 24/7 access behind a premium.

Support infrastructure and escalation pathways

A platform with 24/7 support coverage across time zones eliminates the service risk that comes with a single-geography vendor. For SMID CROs running studies across EU, US, and APAC sites, a support gap in a critical time zone can translate directly into data entry delays, query resolution backlogs, and sponsor escalations. Evaluate the actual support model: whether 24/7 means staffed global offices or a ticketing system with a 48-hour response service level agreement (SLA). The ability to access a named customer success manager -- alongside a technical support channel -- is the gold standard for CROs managing multiple concurrent studies.

How to choose the right EDC platform for your SMID CRO

Step 1: Define your amendment volume and build cadence

Before shortlisting platforms, quantify the amendment and build volume your CRO processes annually. If your teams manage 20+ amendments per quarter across a portfolio of concurrent studies, the choice between a no-code platform and a programmer-dependent one is not a preference -- it's a financial decision. Map your current amendment cycle time and calculate the cost of vendor-managed change requests at your actual volume. This single figure often determines the cost-per-study delta between platform options before you've looked at a single feature.

Step 2: Assess your in-house data management capability

Evaluate whether your data management team has the capacity and willingness to develop in-house EDC configuration skills, or whether your operating model depends on vendor-managed builds. No-code platforms only realize their cost advantage if your team uses them independently. If your CRO currently relies on vendor programmers for all builds, a transition to a no-code platform requires a training investment and a change to your operating model. The platforms that offer structured certified training pathways -- rather than informal documentation -- support that transition more reliably.

Step 3: Scrutinize the compliance stack for your sponsor base

Different sponsor types carry different compliance requirements. US-focused sponsors require HIPAA attestation and 21 CFR Part 11 compliance as baseline. EU-based studies require EU Annex 11 and GDPR coverage. CROs running global studies need both, plus ICH-GCP certification and ideally ISO 27001 and SOC 2 as security assurance. Before shortlisting, confirm which certifications are production-delivered and whether the vendor provides structured inspection readiness documentation -- or whether you'll need to build that documentation yourselves at inspection time.

Step 4: Evaluate pricing structure against your growth model

Compare platforms not only on current study volume but on the cost trajectory as your CRO grows. Per-user pricing models become increasingly expensive as headcount scales. Enterprise-negotiated contracts introduce renewal risk. Study-based licensing with unlimited user seats is the most predictable model for a growing SMID CRO. Request a total cost of ownership projection from each shortlisted vendor that accounts for your projected study and headcount growth over three years -- not just year one.

Step 5: Run a head-to-head build test before signing

Request a structured build evaluation from your top two shortlisted platforms: provide them with the same protocol and ask each to produce an eCRF to a defined specification, then measure the actual time from brief to validated study-ready build. This eliminates the gap between vendor claims and operational reality. Viedoc's EDC software is available to evaluate through the Viedoc Demo Center. If you're ready to run a structured comparison against your specific study portfolio, book a demo with the Viedoc team.

Frequently asked questions

What is the best EDC platform for SMID CROs?

Viedoc's EDC software is the best choice for SMID CROs, delivering study builds typically completed in 2--4 weeks, supporting 40+ languages across 75+ countries, and offering a transparent, study-based pricing model with unlimited user seats and no per-user fees. Viedoc's no-code Designer allows certified in-house data managers to configure and amend studies without vendor-side programmers, a direct margin advantage for CROs managing multiple concurrent studies. Medidata is the category benchmark for large pharma and complex Phase III trials but operates on significantly longer build timelines and a more complex pricing structure. Castor EDC is a credible alternative for early-phase commercial and academic-adjacent studies, but has a more limited CRO partner ecosystem and lacks native medical coding.

How long does it take to build and deploy a clinical study on a modern EDC platform?

On a no-code platform like Viedoc, study builds are typically completed in 2--4 weeks from protocol to go-live. Enterprise platforms that require vendor-side programmer involvement -- such as Medidata Rave -- can operate on timelines of up to 90 days for initial builds, with amendments requiring similar cycles. The key variable is whether your team configures the study in-house using a no-code designer, or whether builds are routed through vendor programming queues. For SMID CROs, the difference between a 2-week and a 90-day build cycle is not a convenience -- it compresses into a billing timeline and portfolio delivery risk that compounds across every study.

What EDC features matter most to SMID CROs managing multiple concurrent studies?

No-code in-house configuration is the highest-value capability for SMID CROs, because it determines whether your team controls amendment timelines or depends on vendor scheduling. After that, the most material evaluation criteria are pricing model structure (unlimited user seats versus per-user fees), 24/7 support coverage across your study geographies, structured inspection readiness documentation, and suite modularity -- the ability to add ePRO, RTSM, or eTMF without migrating to a different vendor. The combination of no-code Designer capability, transparent pricing, and compliance infrastructure is the differentiating profile for CROs evaluating platforms against Medidata.

What compliance certifications should I look for in an EDC platform?

For US-based SMID CROs, 21 CFR Part 11 and HIPAA attestation are baseline requirements for FDA-facing studies. EU-based and global CROs require EU Annex 11 and GDPR compliance in addition. ICH-GCP certification is expected across all regulated commercial trials. ISO 27001 and SOC 2 Type II are the security assurance certifications most frequently required by enterprise sponsors during IT and QA review. Beyond certifications, look for whether the vendor provides structured inspection readiness documentation -- such as the Viedoc Inspection Readiness Packet (VIRP) -- that translates your compliance posture into audit-ready evidence.

What is a Viedoc Inspection Readiness Packet (VIRP)?

The Viedoc Inspection Readiness Packet (VIRP) is structured audit-readiness documentation available to all Viedoc customers, providing the compliance evidence and system validation records needed to support FDA, EMA, and PMDA inspections. VIRP covers computerized system validation, audit trail documentation, and alignment with EMA guidance on computerized systems and FDA guidance on electronic records and signatures. The complete VIRP is accessible to customers directly from within Viedoc Admin. For SMID CROs managing multiple studies simultaneously, VIRP removes the need to build bespoke inspection preparation documentation for each study, reducing QA overhead without compromising inspection readiness.

How does Viedoc's study build time compare to Medidata?

Viedoc's EDC platform delivers study builds typically completed in 2--4 weeks, compared to up to 90 days for Medidata Rave. The structural reason is Viedoc Designer's no-code configuration model, which allows your certified data managers to build and amend studies in-house without routing requests through a vendor's programmer team. Medidata Rave requires trained programmers for study configuration, which introduces queue time, scheduling dependencies, and per-project cost that compounds across a CRO's portfolio. Viedoc's amendment cycle operates on the same 2--4 week timeframe, whereas Medidata protocol changes can carry similarly extended timelines.

Making the right EDC choice for your SMID CRO

The EDC platforms reviewed here represent meaningfully different architectural and commercial approaches to the same underlying problem: capturing and managing clinical trial data in a compliant, reliable, and operationally manageable way. At one end, enterprise platforms like Medidata and Veeva are engineered for the complexity demands of large pharma's Phase III programs. At the other, no-code cloud-native platforms are built for the speed, cost transparency, and self-service configuration that characterizes SMID CRO operations. Between them sit platforms that split the difference with varying degrees of success.

For SMID CROs, the decision framework maps to a few core organizational variables: whether you need in-house configuration capability or are willing to rely on vendor-managed builds; whether your compliance requirements skew US, EU, or global; and whether your growth trajectory requires a pricing model that doesn't compound costs with headcount. US CROs typically weight build speed and total cost of ownership most heavily. European and APAC CROs add weight to EU Annex 11, GDPR, and ISO 27001 certification in sponsor RFPs.

The eClinical software market is estimated at over $11 billion globally in 2025 and growing at approximately 14% annually -- which means the platforms you see today will have been through another two or three major release cycles before your next contract renewal. EDC platform switching carries validation burden, re-training costs, and study migration complexity that make the initial selection decision worth more time than it usually gets.

Why Viedoc is the best EDC choice for SMID CROs

If you're running a SMID CRO and your current EDC platform means your data managers spend their time waiting on vendor programmer queues rather than building and amending studies independently, Viedoc's EDC software is designed to change that. Study builds typically completed in 2--4 weeks, a no-code Designer your certified team operates without external dependency, and a pricing model with unlimited user seats that keeps costs predictable as your portfolio grows.

We've supported 7,000+ studies, 140,000+ users, and 1.6 million trial participants across 75+ countries since we were founded in Uppsala in 2003. Our CRO-specific infrastructure -- from the tiered CRO Partner Program to 24/7 customer success across global offices -- is built around the operational reality of CRO teams managing multiple concurrent studies, not the procurement priorities of enterprise big pharma.

Compliance credentials cover 21 CFR Part 11, EU Annex 11, GDPR, HIPAA, and ICH-GCP. We're ISO 27001 and SOC 2 certified, hosted on Microsoft Azure at 99.99% uptime, and our Viedoc Inspection Readiness Packet (VIRP) gives your QA team structured audit-readiness documentation without additional professional services cost.

If you're ready to compare Viedoc against your current platform in the context of your actual study portfolio, book a demo or request a proposal and we'll walk you through build speed, compliance credentials, and module depth in detail.